BioSyent, Inc.

{
  "main_header": {
    "sid": 1110805,
    "name": "BioSyent, Inc.",
    "stock_name": "BioSyent, Inc.",
    "full_name": "BioSyent, Inc.",
    "name_url": "stocks-analysis/biosyent-inc",
    "exchange": 1,
    "exchangecode": "TSX",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "12.50",
    "chg": 7.24,
    "chgp": "137.64%",
    "dir": 1,
    "prev_price": "5.26",
    "mcapval": "152.05",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P/TSX 60",
    "isin": "CA0906901081",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "5.71 k",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biosyent-inc-1110805-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "BioSyent's Valuation Adjustment Highlights Strong Financial Health and Market Position",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biosyent-upgraded-to-strong-buy-as-valuation-score-improves-to-attractive-3760246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BioSyentInc_mojoScore_3760246.png",
        "date": "2025-12-16 15:44:54",
        "description": "BioSyent, Inc. has recently experienced a change in its evaluation, reflecting a significant shift in its valuation metrics. The company showcases strong financial health, with competitive ratios and impressive performance indicators, including high returns on capital and equity, alongside robust cash generation capabilities."
      }
    ],
    "total": 2,
    "sid": "1110805",
    "stock_news_url": "https://www.marketsmojo.com/news/biosyent-inc-1110805"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

BioSyent's Valuation Adjustment Highlights Strong Financial Health and Market Position

2025-12-16 15:44:54

BioSyent, Inc. has recently experienced a change in its evaluation, reflecting a significant shift in its valuation metrics. The company showcases strong financial health, with competitive ratios and impressive performance indicators, including high returns on capital and equity, alongside robust cash generation capabilities.

Read full news article

View All News